Executive Committee Change

Embargo: Immediate Release External Announcement Reckitt Benckiser Executive Committee Change Frank Ruether, SVP Human Resources, To Retire: Successor Announced After a 13 year distinguished career at Reckitt Benckiser Frank Ruether, SVP Human Resources (HR) and a member of RB's Executive Committee, is retiring from the business, effective 1 July 2009. He is succeeded by Simon Nash, who joins RB from Novartis Consumer Health Care. Frank joined RB in 1996 and was made SVP HR and a member of the executive committee in 1997. Frank was a key player in the 1999 merger of Reckitt & Coleman and Benckiser. Post merger, he led the restructuring of the business from a multi-local organisation into a global matrix organization of countries, categories and functions. Importantly, he helped create RB's highly innovative category development organization. Under his watch, RB has substantially upgraded its bench of talent, so facilitating the company's succession planning. Simon Nash, currently global head of human resources, Novartis Consumer Health, is announced as Reckitt Benckiser SVP HR. Simon has been with Novartis for nearly 10 years and prior to that worked for Fortune Brands, Kraft, Mars and P& G, and has worked in Switzerland, US and UK. - ENDS - For further information contact: Andraea Dawson-Shepherd, Global Director Corporate Communication and Affairs Reckitt Benckiser Group plc, +44 (0) 1753 446 534 Notes to Editors: About Reckitt Benckiser Reckitt Benckiser is a world leader in household, health and personal care. It is a FTSE top 15 company and since 2000 net revenues have doubled and the market cap has quadrupled. Today it is the global No 1 or No 2 in the majority of its fast-growing categories, driven by an exceptional rate of innovation - near 40% of revenue comes from innovations launched in the prior 3 years. It has a strong portfolio led by 17 global powerbrands which are: Finish, Lysol, Dettol, Vanish, Woolite, Calgon, Airwick, Harpic, Bang, Mortein, Veet,, Nurofen, Clearasil, Strepsils Gaviscon, Mucinex and French's, and they account for over two thirds of its net revenue. Reckitt Benckiser people are at the heart of the company's success. They have an intense drive for progress and action and a desire to outperform wherever they focus, including in CSR where the Company has the most ambitious corporate responsibility programme in the industry through its Carbon 20 initiative. Headquartered in the United Kingdom, the Company employs 23,000 people worldwide, with operations in 60 countries and sales in 180 countries. For more information visit RECKITTBENCKISER.COM
UK 100

Latest directors dealings